图书馆订阅: Guest
Begell Digital Portal Begell 数字图书馆 电子图书 期刊 参考文献及会议录 研究收集
医药载体系统评论综述
影响因子: 2.9 5年影响因子: 3.72 SJR: 0.736 SNIP: 0.551 CiteScore™: 2.43

ISSN 打印: 0743-4863
ISSN 在线: 2162-660X

医药载体系统评论综述

DOI: 10.1615/CritRevTherDrugCarrierSyst.v26.i4.10
pages 333-372

Paclitaxel in Cancer Treatment: Perspectives and Prospects of its Delivery Challenges

Somnath Singh
Department of Pharmacy Sciences, School of Pharmacy and Health Professions, Creighton University, Omaha, Nebraska
Alekha K. Dash
Creighton University

ABSTRACT

Paclitaxel (PTX) is a potent anticancer agent whose clinical usefulness is marred by a delivery problem that is caused by its unfavorable pharmacokinetic and physical properties. Paclitaxel is currently formulated in a mixture of Cremophor EL and ethanol, which is diluted 5−20 times with normal saline or 5% dextrose prior to administration via slow infusion to avoid precipitation in plasma. Many adverse reactions to the PTX formulation have been reported because of the presence of Cremophor EL, including hypersensitivity reactions, nephrotoxicity, and neurotoxicity. Cremophor EL also causes vasodilation, labored breathing, lethargy, hypotension, and leaching of plasticizers, such as diethylhexylpthalate, from the polyvinylchloride infusion bags/sets. Significant research efforts have been conducted to develop an alternative formulation approach to increase the aqueous solubility of PTX without using Cremophor, thereby decreasing its toxicity. This article reviews the various investigated formulation approaches including pastes; liposomes; conjugates with antibodies, peptides, and fatty acids; nanospheres and microspheres; cyclodextrin complexes; emulsions; mucoadhesive gel; prodrugs; and nanoparticulate systems. The pros and cons of each approach are also discussed. Finally, this review concludes with a discussion of nanoparticulate delivery, which is the most promising PTX delivery system of the future because it incorporates the benefits of other approaches such as conjugation, complexation, and prodrugs.


Articles with similar content:

Heparin-Tailored Biopolymeric Nanocarriers in Site-Specific Delivery: A Systematic Review
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.34, 2017, issue 1
Awesh K. Yadav, Rajeev Sharma, Ashish Garg, Vikas Pandey, Vaibhav Patel
Enhancement of Ocular Drug Penetration
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.16, 1999, issue 1
Junzo Nakamura, Mikiro Nakashima, Masataka Ichikawa, Takahiro Mukai, Hitoshi Sasaki, Kenzo Yamamura, Koyo Nishida
Recent Advances in the Stabilization of Proteins Encapsulated in Injectable PLGA Delivery Systems
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.19, 2002, issue 1
Steven P. Schwendeman
Enhancement of Transdermal Delivery of Heparin by Various Physical and Chemical Enhancement Techniques
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.26, 2009, issue 6
S. S. Lanke, Ajay K. Banga, J. G. Strom
The Synthesis of C8-Aryl Purines, Nucleosides and Phosphoramidites
Critical Reviews™ in Eukaryotic Gene Expression, Vol.21, 2011, issue 2
Nissa M. Thomsen, Peter Gannett, Vorasit Vongsutilers